canagliflozin · Powder

What changed in the last 90 days

Every detected change for canagliflozin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Sodium-Glucose Cotransporter 2 Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• dapagliflozin and saxagliptin· 1 maker
• empagliflozin and linagliptin· 1 maker
• empagliflozin, linagliptin, metformin hydrochloride· 1 maker
• empagliflozin, metformin hydrochloride· 1 maker
• canagliflozin and metformin hydrochloride· 2 makers
• empagliflozin and metformin hydrochloride· 2 makers
• sotagliflozin· 2 makers
• bexagliflozin· 3 makers
• dapagliflozin and metformin hydrochloride· 9 makers
• empagliflozin· 31 makers
• dapagliflozin· 40 makers

Common questions

Is Canagliflozin in shortage right now?

No. FDA does not currently list Canagliflozin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Canagliflozin?

12 companies have marketed Canagliflozin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Canagliflozin cost?

The typical pharmacy pays about $19.11 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.